Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Share News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,940.00    -110.00 (-1.56%)
Bid:
6,935.00
Ask:
6,945.00
Spread: 10.00 (0.144%)
Market Cap: £5.12b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Spirax-Sarco News

UK BROKER RATINGS SUMMARY: Bank of America Cuts HSBC And Raises Croda
7 Dec 2020

UK BROKER RATINGS SUMMARY: Bank of America Cuts HSBC And Raises Croda

UK BROKER RATINGS SUMMARY: Bank of America Cuts HSBC And Raises Croda

UK BROKER RATINGS SUMMARY: UBS Upgrades AstraZeneca To Neutral
30 Nov 2020

UK BROKER RATINGS SUMMARY: UBS Upgrades AstraZeneca To Neutral

UK BROKER RATINGS SUMMARY: UBS Upgrades AstraZeneca To Neutral

UK BROKER RATINGS SUMMARY: Citigroup Lifts Croda To Buy From Neutral
20 Nov 2020

UK BROKER RATINGS SUMMARY: Citigroup Lifts Croda To Buy From Neutral

UK BROKER RATINGS SUMMARY: Citigroup Lifts Croda To Buy From Neutral

LONDON MARKET CLOSE: Stocks Rise As Pfizer Says Vaccine 95% Effective
18 Nov 2020

LONDON MARKET CLOSE: Stocks Rise As Pfizer Says Vaccine 95% Effective

LONDON MARKET CLOSE: Stocks Rise As Pfizer Says Vaccine 95% Effective

LONDON MARKET MIDDAY: Stocks Edge Up As Markets Calm After Vaccine Joy
18 Nov 2020

LONDON MARKET MIDDAY: Stocks Edge Up As Markets Calm After Vaccine Joy

LONDON MARKET MIDDAY: Stocks Edge Up As Markets Calm After Vaccine Joy

UK WINNERS & LOSERS SUMMARY: Micro Focus Shares Jump 28% On Margins
18 Nov 2020

UK WINNERS & LOSERS SUMMARY: Micro Focus Shares Jump 28% On Margins

UK WINNERS & LOSERS SUMMARY: Micro Focus Shares Jump 28% On Margins

UK BROKER RATINGS SUMMARY: UBS And Goldman Both Cut Compass To Neutral
18 Nov 2020

UK BROKER RATINGS SUMMARY: UBS And Goldman Both Cut Compass To Neutral

UK BROKER RATINGS SUMMARY: UBS And Goldman Both Cut Compass To Neutral

TOP NEWS: Spirax-Sarco Sees Some Recovery But Wary Of Virus Resurgence
18 Nov 2020

TOP NEWS: Spirax-Sarco Sees Some Recovery But Wary Of Virus Resurgence

TOP NEWS: Spirax-Sarco Sees Some Recovery But Wary Of Virus Resurgence